CORVAJA, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 774
EU - Europa 104
AS - Asia 77
AF - Africa 3
Totale 958
Nazione #
US - Stati Uniti d'America 774
IT - Italia 31
VN - Vietnam 31
CN - Cina 25
BE - Belgio 17
DE - Germania 15
IE - Irlanda 15
IN - India 10
UA - Ucraina 10
SG - Singapore 6
GB - Regno Unito 5
IR - Iran 5
RU - Federazione Russa 5
TG - Togo 3
CZ - Repubblica Ceca 2
AT - Austria 1
BY - Bielorussia 1
FI - Finlandia 1
NL - Olanda 1
Totale 958
Città #
Ann Arbor 92
Chandler 89
Fairfield 88
Ashburn 74
Seattle 46
Houston 39
Woodbridge 34
Wilmington 33
Dong Ket 31
Cambridge 23
Redmond 21
Beijing 18
New York 18
Brussels 17
Dublin 15
Princeton 15
Jacksonville 9
Los Angeles 9
San Diego 8
Dearborn 6
Ogden 6
Singapore 6
Washington 5
Augusta 4
Boardman 3
Caserta 3
Leawood 3
Lomé 3
Ardabil 2
Brno 2
Des Moines 2
Jinan 2
Milan 2
Nanchang 2
Nanjing 2
Norwalk 2
Sagrado 2
Treviso 2
Trieste 2
Udine 2
Verona 2
Amsterdam 1
Dallas 1
Helsinki 1
Hyderabad 1
Langfang 1
London 1
Melfi 1
Mortegliano 1
New Delhi 1
Phoenix 1
Redwood City 1
Sabz 1
San Mateo 1
San Remo 1
Venezia 1
Vienna 1
Totale 760
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 118
Emerging Role of Genomics and Cell-Free DNA in Breast Cancer 113
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 80
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 79
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 75
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 74
Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients 61
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 61
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 56
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 38
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 35
Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave 33
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 31
A multi-center, real-life experience on liquid biopsy practice for EGFR testing in non-small cell lung cancer (NSCLC) patients 30
Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies 19
Immunotherapy in NSCLC Patients with Brain Metastases 14
Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance 10
Targeting HER3 for cancer treatment: a new horizon for an old target 6
The use of liquid biopsy in early breast cancer: clinical evidence and future perspectives 5
Totale 1.022
Categoria #
all - tutte 4.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020206 0 11 3 12 13 16 16 15 47 46 20 7
2020/2021305 14 19 58 33 29 15 9 25 6 18 29 50
2021/2022160 8 19 0 2 4 0 12 6 14 22 58 15
2022/2023206 19 33 4 27 22 42 3 8 31 1 8 8
2023/2024140 11 6 6 5 26 48 0 1 10 12 1 14
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.022